Thought Leadership | Fish & Richardson

Diversity, Equity & Inclusion

Pro Bono & Social Responsibility

Legal Operations

Legal Project Management

Knowledge Management

Legal Technology Services

Patent Litigation

Trademark, Copyright & Media Litigation

Trade Secret Litigation

Chancery & Corporate Governance

<p><em>Inter Partes </em>Review</p>

Post-Grant Review

<p><em>Ex Parte</em> Reexamination</p>

Supplemental Examination

Patent Prosecution

Strategic Patent Counseling & Opinions

Patent Portfolio Management

Unitary Patent & Unified Patent Court

IP Licensing, Transactions & Agreements

Trademark & Copyright Counseling & Prosecution

Strategic Counseling, Registration & Opinions

Advertising & Marketing

Domain Names & Internet

TTAB Oppositions & Cancellations

Digital Millennium Copyright Act

Transactions & Agreements

Regulatory & Government Affairs

Communications & Spectrum Regulation

Drug & Medical Device Regulation

mHealth & Telemedicine

Privacy & Data Security

Electrical & Computer Technology

Software & Internet

Consumer Electronics

Artificial Intelligence

Digital Media & E-Commerce

Financial, Business & FinTech Services

Telecommunications

Energy & Chemicals

Biotech & Diagnostics

Medical Devices

Pharmaceuticals

Academic Research & Medical Centers

Transportation, Aerospace & Defense

Autonomous Vehicles

Thought Leadership

IP Law Essentials

Post-Grant Annual Reports

Blog | April 10, 2020

Keeping Up With Life Sciences Appeals: 1Q2020

Blog | April 08, 2020

Essential Steps Every Brand Owner Should Take to Combat Counterfeiting

Blog | April 02, 2020

Supreme Court Rules States "Arrrrgh" Immune from Copyright Infringement Suits

Blog | April 02, 2020

Section 101: Cert. Denied ... Now What?

Blog | March 31, 2020

Legal Alert: POP Designates Two Discretionary Denial Decisions Precedential

Blog | March 31, 2020

EDTX Monthly Wrap-Up March 2020

Article | March 31, 2020

Fish Attorneys Author Law360 Article, "Client Advocacy Tips For Remote Hearings During COVID-19"

Blog | March 27, 2020

Led Zeppelin Paves the Way for Katy Perry

Blog | March 26, 2020

Federal Circuit Denies Rehearing in Arthrex v. Smith & Nephew

Blog | March 24, 2020

Michael Hawkins Quoted in Law360 Article: "Ban On IPR Time-Bar Tricks Will Spur New Strategies"

Blog | March 23, 2020

Legal Alert: Federal Circuit Says PTAB Joinder Rules Contrary to Law

Blog | March 20, 2020

Insulin and Other Biological Products Previously Regulated as "Drugs" Transition to Biologics Regulation on March 23, 2020